SeaStar Medical Changes Fiscal Year End

TL;DR

SeaStar Medical (SEA) is changing its fiscal year end to 12/31, effective April 12, 2024.

AI Summary

SeaStar Medical Holding Corp. filed an 8-K on April 18, 2024, reporting a change in its fiscal year end to December 31st. This filing also includes financial statements and exhibits, with the earliest event reported being April 12, 2024. The company was formerly known as LMF Acquisition Opportunities Inc. and changed its name on November 9, 2020.

Why It Matters

A change in fiscal year end can impact reporting schedules and financial comparisons for investors. This filing clarifies SeaStar Medical's new reporting cycle.

Risk Assessment

Risk Level: low — This filing primarily concerns administrative changes to the company's reporting structure and does not appear to involve significant financial or operational risks.

Key Numbers

• 12/31 — New Fiscal Year End (SeaStar Medical Holding Corp. has updated its fiscal year end to December 31st.)

Key Players & Entities

• SeaStar Medical Holding Corp (company) — Registrant
• LMF Acquisition Opportunities Inc (company) — Former Company Name
• April 12, 2024 (date) — Earliest event reported
• April 18, 2024 (date) — Date of Report
• November 9, 2020 (date) — Date of Name Change
• December 31 (date) — New Fiscal Year End

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock par value $0.0001 per share ICU NASDAQ Warrants, ea
• $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW NASDAQ Indicate b

Filing Documents

• a8k.htm (8-K) — 32KB
• exhibit3-1.htm (EX-3.1) — 113KB
• 0000929638-24-001521.txt ( ) — 326KB
• icu-20240412.xsd (EX-101.SCH) — 4KB
• icu-20240412_def.xml (EX-101.DEF) — 18KB
• icu-20240412_lab.xml (EX-101.LAB) — 27KB
• icu-20240412_pre.xml (EX-101.PRE) — 20KB
• a8k_htm.xml (XML) — 6KB

03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On April 12, 2024, the Board of Directors (the "Board") of SeaStar Medical Holding Corporation (the "Company") approved the amendment and restatement of the Company's Amended and Restated Bylaws (the "Second Amended and Restated Bylaws") to, among other things: reduce the quorum threshold for meetings of stockholders from the holders of a majority of the common stock of the Company issued and outstanding and entitled to vote to the holders of at least 33 1/3% of the common stock of the Company issued and outstanding and entitled to vote; and remove the "Acting in Concert" definition and provisions in Section 2.12(a) and Section 2.12(b), so that a Proposing Stockholder (as defined in the Second Amended and Restated Bylaws) does not include a person who is "Acting in Concert" with any such stockholder or beneficial owner (or their respective affiliates and associates). The foregoing summary of the Second Amended and Restated Bylaws is qualified in its entirety by reference to the text of the bylaws, which is attached as Exhibit 3.1 to this Form 8-K and is incorporated by reference into this Item 5.03.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description Exhibit 3.1 Second Amended and Restated Bylaws of SeaStar Medical Holding Corporation Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: April 18, 2024 Name: Eric Schlorff Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR